Revvity to Present at Upcoming Investor Conferences

Rhea-AI Summary

Revvity (NYSE: RVTY) has announced its participation in two upcoming investor conferences in September 2024. The company will present at the 2024 Wells Fargo Healthcare Conference in Boston on September 4, with CFO Max Krakowiak speaking at 8:45 a.m. ET. Additionally, Revvity will attend the 2024 Baird Global Healthcare Conference in New York City on September 10, where Steve Willoughby, SVP of investor relations, ESG, and risk, will present at 12:15 p.m. ET.

Both presentations will provide updates on Revvity's strategic priorities and will be available via live audio webcasts on the company's website. Replays will be accessible for at least 30 days after the events on the Revvity Investor Relations website.

WALTHAM, Mass.--(BUSINESS WIRE)-- Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences in September 2024:

2024 Wells Fargo Healthcare Conference – Boston, MA
Wednesday, September 4, 2024
8:45 a.m. ET - Max Krakowiak, senior vice president and chief financial officer

2024 Baird Global Healthcare Conference – New York City, NY
Tuesday, September 10, 2024
12:15 p.m. ET - Steve Willoughby, senior vice president, investor relations, ESG, risk

Attendees will receive an update on the Company and its strategic priorities.

Live audio webcasts will be available on the Events section of the Company’s website. Replays of the presentations will be posted on the Revvity Investor Relations website after the events and will be available for at least 30 days.

About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.

With 2023 revenue of more than $2.7 billion and over 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 190 countries.

Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240821240750/en/

Media Relations:

Chet Murray

(781) 462-5126

chet.murray@revvity.com

Investor Relations:

Steve Willoughby

steve.willoughby@revvity.com

Source: Revvity

FAQ

When and where will Revvity (RVTY) present at the Wells Fargo Healthcare Conference in 2024?

Revvity (RVTY) will present at the 2024 Wells Fargo Healthcare Conference in Boston, MA on Wednesday, September 4, 2024, at 8:45 a.m. ET.

Who will represent Revvity (RVTY) at the 2024 Baird Global Healthcare Conference?

Steve Willoughby, senior vice president of investor relations, ESG, and risk, will represent Revvity (RVTY) at the 2024 Baird Global Healthcare Conference.

How can investors access Revvity's (RVTY) presentations at the September 2024 conferences?

Investors can access live audio webcasts of Revvity's (RVTY) presentations on the Events section of the company's website. Replays will be available on the Revvity Investor Relations website for at least 30 days after the events.

What topics will Revvity (RVTY) cover in its September 2024 investor conference presentations?

Revvity (RVTY) will provide attendees with updates on the company and its strategic priorities during the September 2024 investor conference presentations.